title: Tuberculosis reactivation in hepatocellular carcinoma: association with transarterial chemoembolization.
abstract: Transarterial chemoembolization (TACE) is an important therapeutic option for patients with hepatocellular carcinoma (HCC). We discuss five patients with HCC and tuberculosis (TB) reactivation following TACE. Screening patients for latent TB infection at diagnosis of cirrhosis or HCC should be considered because of the immunosuppression inherent in both the diseases and their treatments.
authors: From the Infectious Diseases Section, Medical Service, Veterans Affairs Medical Center , Washington, DC , USA.
authors: Ann M
authors: AM
authors: Laake
authors: Angelike P
authors: AP
authors: Liappis
authors: Elizabeth
authors: E
authors: Guy
authors: Gail
authors: G
authors: Kerr
authors: Debra A
authors: DA
authors: Benator
mesh_terms: D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000628:therapy; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects*; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D014376:Tuberculosis
keywords: Cirrhosis; hepatocellular carcinoma; transarterial chemoembolization; tuberculosis reactivation